With seamless site changes and fast software iteration, Beta Bionics’ upcoming patch pump could challenge the pace and expectations of the tubeless pump market.
The pump currently in development allows users to change sites without a phone—potentially reshaping the tubeless landscape and pushing rivals to move faster.
Tandem, Beta Bionics, Sequel Med Tech, and Ypsomed are the first to announce integration plans for Abbott’s dual-analyte sensor with more expected.
